BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, July 15, 2026
Breaking News: Ongoing coverage of the Ebola outbreak
Breaking News: Celia trial: data strong, analysts skeptical
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
Wellstat Therapeutics developing URAT1 inhibitors for the treatment of gout
Dec. 28, 2009
Vitae Pharmaceuticals and Boehringer Ingelheim claim novel antiobesity agents
Dec. 28, 2009
Roche discloses CPT-2 inhibitors for the treatment of type 2 diabetes
Dec. 28, 2009
Shire submits BLA to the FDA for Replagal, updates Gaucher disease therapy
Dec. 28, 2009
EMEA recommends withdrawal of benfluorex from the market in E.U.
Dec. 28, 2009
PDL and Lilly sign license agreement for teplizumab and other anti-CD3 molecules
Dec. 24, 2009
CPEX completes enrollment in phase IIa Nasulin trial
Dec. 24, 2009
Insulin secretion stimulators in development Merck KGaA for type 2 diabetes therapy
Dec. 24, 2009
Novel GK activators for the treatment of diabetes presented by Roche
Dec. 24, 2009
Bristol-Myers Squibb claims DGAT-1 inhibitors for the treatment of obesity
Dec. 24, 2009
Previous
1
2
…
725
726
727
728
729
730
731
732
733
…
1800
1801
Next
RSS